Codes / ICD10CM / T45.1X5

T45.1X5 Adverse effect of antineoplastic and immunosuppressive drugs

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of antineoplastic and immunosuppressive drugs (ICD-10 code: T45.1X5)

Summary

This condition describes negative reactions or side effects resulting from the use of antineoplastic (cancer-fighting) and immunosuppressive drugs. These medications are critical for treating malignancies, autoimmune diseases, or preventing organ transplant rejection but can cause harmful effects on the body.

Causes

Adverse effects are caused by the toxic properties of the drugs, which may damage healthy cells while targeting diseased cells. Factors such as dosage, drug type, and individual susceptibility influence the occurrence and severity of these reactions.

Risk Factors

  • High dosages or prolonged use of medication.
  • Pre-existing health conditions affecting organ function (e.g., renal or hepatic impairment).
  • Age-related changes in drug metabolism (e.g., older adults or pediatric patients).
  • Concurrent use of other medications that interact with antineoplastic/immunosuppressive agents.
  • Individual metabolic differences or genetic predispositions.

Symptoms

Symptoms may include nausea, vomiting, fatigue, hair loss, bone marrow suppression (e.g., low blood counts), increased infection risk, and organ dysfunction (e.g., kidney or liver damage). Severity varies widely between individuals.

Diagnosis

Diagnosis is based on a comprehensive review of the patient's medication history and presenting symptoms. Additional tests, such as blood work, imaging, or organ function assessments, may be used to evaluate the extent of adverse effects.

Treatment Options

Treatment focuses on managing symptoms and supporting organ function. This may include discontinuing or adjusting the offending drug, administering supportive care (e.g., antiemetics, blood transfusions), or using specific antidotes if available. Symptomatic relief and monitoring are key components of care.

Prognosis and Follow-Up

Prognosis depends on the severity of the adverse effect, the specific drug involved, and the patient's overall health. Most mild to moderate reactions resolve with treatment, but severe cases may require long-term management. Regular follow-up is essential to monitor recovery and adjust therapy as needed.

Complications

Complications can include organ failure (e.g., renal or hepatic), severe infections due to immunosuppression, or prolonged cytopenias (low blood cell counts). In rare cases, adverse effects may be life-threatening.

Lifestyle & Prevention

Patients should follow prescribed dosing schedules and report new symptoms promptly. Healthcare providers may adjust dosages or switch medications to minimize risks. Proper storage and handling of these drugs, especially in home settings, can reduce accidental exposure.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as severe nausea, uncontrolled vomiting, fever, unusual bleeding, or signs of organ dysfunction (e.g., jaundice, reduced urine output) occur. Early intervention can prevent complications.

Tips for Medical Coders

Document the specific drug(s) involved, the nature of the adverse effect (e.g., organ-specific toxicity), and the clinical context (e.g., timing relative to drug administration). Ensure the code aligns with the patient's documented symptoms and treatment. Use additional codes (e.g., for organ dysfunction) as needed to capture the full clinical picture.

Book a walkthrough

T45.1X5 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.